Insulin secretion and sensitivity in newly diagnosed NIDDM caucasians in the UK

Diabetic Medicine

Volumn 13, Issue SUPPL. 6, 1996, Pages

  Owens, D R ^a,b   Luzio, S D ^a   Coates, P A ^a  

^a LLANDOUGH HOSPITAL   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Healthy subjects; Insulin secretion; Insulin sensitivity; NIDDM; Proinsulin

Indexed keywords

INSULIN; PROINSULIN;

ADULT; AGED; CONFERENCE PAPER; CONTROLLED STUDY; ETHNOLOGY; GLUCOSE TOLERANCE TEST; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS;

EID: 0029837035     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/dme.1996.13.s6.19     Document Type: Conference Paper

References (20)

1. DeFronzo RA. Pathogenesis of Type 2 (non-insulin dependent) diabetes mellitus: a balanced overview. Diabetologia 1992; 35: 389-397.
2. Hales CN, Barker DJP. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992; 35: 595-601.
3. Kahn CR. Insulin action, diabetogenes, and the cause of Type II diabetes. Diabetes 1994; 43: 1066-1084.
4. Yki-Järvinen H. Pathogenesis of non-insulin-dependent diabetes mellitus. Lancet 1994; 343: 91-100.
5. Taylor SI, Accili D, Imai Y. Perspectives in diabetes. Insulin resistance or insulin deficiency - which is the primary cause of NIDDM? Diabetes 1994; 43: 735-740.
6. Coates PA, Ollerton RL, Luzio SD, Ismail I, Owens DR. A glimpse of the 'natural history' of established Type 2 (non-insulin dependent) diabetes mellitus from the spectrum of metabolic and hormonal responses to a mixed meal at the time of diagnosis. Diab Res Clin Prac 1994; 26: 177-178.
7. Temple R, Clark PMS, Hales CN. Measurement of insulin secretion in Type 2 diabetes; problems and pitfalls. Diabetic Med 1992; 9: 503-512.
8. Granner DK, O'Brien RM. Molecular physiology and genetics of NIDDM: importance of metabolic staging. Diab Care 1992; 15: 369-395.
9. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 1969; 6: 24-27.
10. Heding LG. Radioimmunological determination of human C-peptide in serum. Diabetologia 1973; 11: 541-548.
11. Heding LG. Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia 1972; 8: 260-266.
12. Andersen L, Dinesen B, Jorgensen PN, Poulsen F, Roder ME. Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 1993; 39: 578-582.
13. Kjems LL, Roder ME, Dinesen B, Hartling SG, Jorgensen PN, Binder C. Highly sensitive enzyme immunoassay of proinsulin immunoreactivity with use of two monoclonal antibodies. Clin Chem 1993; 39: 2146-2150.
14. Vølund A, Polonsky KS, Bergman RN. Calculated pattern of intraportal insulin appearance without independent assessments of C-peptide kinetics. Diabetes 1987; 35: 1195-1202.
15. Watanabe RM, Vølund A, Roy S, Perlman JA, Bergman RN. Prehepatic beta-cell secretion during the intravenous glucose tolerance test in humans: application of a combined model of insulin and C-peptide kinetics. J Clin Endocrinol Metab 1989; 69: 790-797.
16. 6. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol 1979; 236: E667-E777.
17. Yoshioka N, Kuzuya T, Matsuda A, Taniguchi M, Iwamoto Y. Serum proinsulin levels at fasting and after oral glucose load in patients with Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1988; 31: 355-360.
18. Temple RC, Carrington CA, Luzio SD, Owens DR, Schneider AE, Sobey WJ, Hales CN. Insulin deficiency in non-insulin-dependent diabetes. Lancet 1989; 1: 293-295.
19. Davies MJ, Metcalfe J, Gray IP, Day JL, Hales CN. Insulin deficiency rather than hyperinsulinaemia in newly diagnosed Type 2 diabetes mellitus. Diabetic Med 1993; 10: 305-312.
20. Davies MJ, Metcalfe J, Day JL, Grenfell A, Hales CN, Gray IP. Improved beta cell function, with reduction in secretion of intact and 32/33 split proinsulin after dietary intervention in subjects with Type 2 diabetes mellitus. Diabetic Med 1994; 11: 71-78.